Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 4CNS 2

Conditions

Brain Neoplasms 2313Glioblastoma 2016Glioma 1402Central Nervous System Neoplasms 692Astrocytoma 668Neuroblastoma 647Gliosarcoma 480Oligodendroglioma 405Neoplasms 405Breast Neoplasms 327Medulloblastoma 307Carcinoma, Non-Small-Cell Lung 256Meningioma 229Recurrence 224Sarcoma 215Melanoma 207Neoplasm Metastasis 202Ependymoma 200Lung Neoplasms 199Neurofibromatosis 1 169Lymphoma 162Meningeal Carcinomatosis 138Osteosarcoma 135Ovarian Neoplasms 132Wilms Tumor 123Precursor Cell Lymphoblastic Leukemia-Lymphoma 123Head and Neck Neoplasms 117Lymphoma, Non-Hodgkin 116Diffuse Intrinsic Pontine Glioma 113Rhabdomyosarcoma 107

Interventions

Lovastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Learning Disabilities × CNS × Clear all
NCT00624234 2025-07-08

Neurobiology and Treatment of Reading Disability in NF-1

Vanderbilt University

Phase NA Completed
184 enrolled 10 charts
CNS

Dyslexia, Learning Disabilities, Neurofibromatosis 1

NCT02964884 2025-06-24

Interventions for Reading Disabilities in NF1

Vanderbilt University

Phase 2 Active not recruiting
120 enrolled
CNS

Dyslexia, Learning Disabilities, Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡